The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Risks of testosterone-replacement therapy and recommendations for monitoring.
Abstract
Although some reports suggest that testosterone-replacement therapy may provide benefits for aging men, considerable controversy remains regarding indications for its use. Neither large-scale nor long-term studies have been initiated, in part because of theoretical concern regarding the risks associated with testosterone therapy, especially the possible stimulation of prostate cancer. This article discusses what is known (and not known) about the risks of testosterone-replacement therapy and provides recommendations for monitoring men who are receiving testosterone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unfortunately, hormone replacement therapy is not a panacea, as it often results in various adverse events which outweigh its potential health benefits.”
From Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications (2021) · cites this paper as [12]
In the citing paper
“preventing an age-related decline in hormones by exogenous replacement is associated with increased risk for adverse effects in older adults.11-13”
From Hormonal and Metabolic Changes of Aging and the Influence of Lifestyle Modifications (2021) · cites this paper as [12]
In the citing paper
“However, testosterone may have deleterious actions on prostate disease, sleep apnea, and possibly cardiovascular risk (35).”
From Low testosterone levels are common and associated with insulin resistance in men with diabetes (2008) · cites this paper as [35]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065
Huggins, C. (1941) · Archives of Surgery · doi:10.1001/archsurg.1941.01210140043004 · Cited by 1,694
Longitudinal Evaluation of Prostate-Specific Antigen Levels in Men With and Without Prostate Disease
Carter, H. B. (1992) · JAMA · doi:10.1001/jama.1992.03480160073037 · Cited by 1,076
Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R., Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., & Ross, C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3988 · Cited by 920
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782
The Frequency of Carcinoma and Intraepithelial Neoplasia of the Prostate in Young Male Patients
Sakr, W., Haas, G. P., Cassin, B. F., Pontes, J. E., & Crissman, J. D. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35487-3 · Cited by 744
Huggins, C., & Hodges, C. (2002) · Journal of Urology · doi:10.1016/s0022-5347(02)80307-x · Cited by 637
Research works printed but not linked: 11
- 10.1210/jc.86.2.724 · DOI · Paper page
- 10.1210/jc.82.6.1661 · DOI
- 10.1210/jc.83.10.3443 · DOI
- 10.1210/jc.82.11.3793 · DOI
- 10.1210/jc.87.1.136 · DOI
- 10.1210/jc.87.4.1467 · DOI
- Barrett-Connor EL, 1995, Diabetes Metab, 21, 156
- 2002, Endocr Rep, 2, 1
- 10.1210/jc.86.6.2380 · DOI
- Westaby D, 1977, Lancet, 2, 262
- 10.1345/aph.1A020 · DOI · Paper page
Cited by
Sorted by citations
Items 401–500 of 713
Surgical and pharmacological reassignment: influence on transsexual cardiovascular risk profile
Ciccone, M. M., Loverro, G., Scicchitano, P., Loverro, M., Ricci, G., Scaramuzzi, F., Gesualdo, M., Zito, A., Campagna, M., Moncelli, M., et al. (2017) · Internal Medicine Journal · doi:10.1111/imj.13597 · Cited by 10
Levčíkova, M., Breza, J., Jr., Luha, J., Dubravicky, J., Kovacova, E., & Fillo, J. (2017) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2017_124 · Cited by 10
EFFECT OF EURYCOMA LONGIFOLIA ON SEXUAL BEHAVIOR IN SEXUALLY DYSFUNCTIONAL MALE: A SYSTEMATIC REVIEW
Jayusman, P. A., Mohamed, I. N., Thu, H. E., & Shuid, A. N. (2017) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2017v9i12.21812 · Cited by 10
Kadekawa, K., Kawamorita, N., Shimizu, T., Kurobe, M., Turnbull, P., Chandra, S. A. M., Kambara, T., Barton, J. C., Russell, A. J., & Yoshimura, N. (2020) · British Journal of Urology · doi:10.1111/bju.15022 · Cited by 10
Ageing male syndrome, andropause, androgen decline or mid-life crisis?
Charlton, R. C. (2004) · The Journal of Men s Health and Gender · doi:10.1016/j.jmhg.2004.03.014 · Cited by 10
Clinical experiences with testosterone therapy: prostate safety
Ebert, T. (2004) · The Aging Male · doi:10.1080/13685530400016680 · Cited by 10
Crum, N. F., Furtek, K. J., Olson, P. E., Amling, C. L., & Wallace, M. R. (2005) · AIDS Patient Care and STDs · doi:10.1089/apc.2005.19.869 · Cited by 10
Testosterone and Prostate Cancer
Tubaro, A. (2006) · European Urology · doi:10.1016/j.eururo.2006.08.048 · Cited by 10
Pearson, H. (2004) · Nature · doi:10.1038/431500a · Cited by 10
Transversal European survey on testosterone deficiency diagnosis
Behre, H. M., Christin‐Maître, S., Morales, A. M., & Tostain, J. (2012) · The Aging Male · doi:10.3109/13685538.2012.655704 · Cited by 9
Profile of endocrinological derangements affecting PSA values in patients with COPD.
Karakou, E., Glynos, C., Samara, K. D., Msaouel, P., Koutsilieris, M., & Vassilakopoulos, T. (2013) · PubMed · Cited by 9
Investigating the basis of sexual dysfunction during late-onset hypogonadism
Tharakan, T., Miah, S., Jayasena, C. N., & Minhas, S. (2019) · F1000Research · doi:10.12688/f1000research.16561.1 · Cited by 9
Testosterona sérica e doença cardiovascular em homens
de Sá, E. Q. C., de Sá, F. C. F., Guedes, A. D., & Verreschi, I. T. N. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000800004 · Cited by 9
Horie, S., Hisasue, S., Nakao, M., Ide, H., China, T., Nagae, M., Saito, K., Isotani, S., Yamaguchi, R., Muto, S., et al. (2013) · The Aging Male · doi:10.3109/13685538.2013.801436 · Cited by 9
The Management of Hypogonadism in Aging Male Patients
Sharma, V., & Perros, P. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.01.1960 · Cited by 8
Półtorak, A., Marcinkowska‐Lesiak, M., Lendzion, K., Onopiuk, A., Moczkowska-Wyrwisz, M., Wojtasik‐Kalinowska, I., & Wierzbicka, A. (2018) · Food Science and Technology · doi:10.1590/fst.03018 · Cited by 9
Brass, L. M. (2004) · Current Treatment Options in Neurology · doi:10.1007/s11940-004-0004-9 · Cited by 9
Novaes, L. F., Flores, J. M., Benfante, N. E., Schofield, E., Katz, D. J., Nelson, C. J., & Mulhall, J. P. (2024) · The Journal of Sexual Medicine · doi:10.1093/jsxmed/qdae026 · Cited by 9
Chowdhury, A., Eddin, A. S., Hsieh, S. K., & Policeni, F. C. (2024) · Journal of Breast Imaging · doi:10.1093/jbi/wbae016 · Cited by 8
Recurrence of prostate cancer in patients receiving testosterone supplementation for hypogonadism
Gray, H., Seltzer, J., & Talbert, R. L. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140128 · Cited by 8
Late-onset hypogonadism or ADAM: diagnosis
Martits, A., Costa, E., Nardi, A., Nardozza, A., Faria, G., Facio, F., & Bernardo, W. (2014) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.60.04.003 · Cited by 8
Kumagai, H., Myoenzono, K., Yoshikawa, T., Tsujimoto, T., Shimomura, K., & Maeda, S. (2020) · The Aging Male · doi:10.1080/13685538.2020.1724940 · Cited by 8
van der Burgh, A. C., Aribas, E., Ikram, M. A., Kavousi, M., Neggers, S. J. C. M. M., Hoorn, E. J., & Chaker, L. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.04.015 · Cited by 8
Nishizaki, Y., Akira, K. U. B. O., Kuwahira, I., Tanino, R., Ogawa, T., & Ishii, N. (2011) · Health Evaluation and Promotion · doi:10.7143/jhep.38.537 · Cited by 8
Switch to restoration therapy in a testosterone treated central hypogonadism with erythrocytosis
Cangiano, B., Cacciatore, C., Persani, L., & Bonomi, M. (2017) · Endocrinology, Diabetes & Metabolism Case Reports · doi:10.1530/edm-17-0055 · Cited by 8
Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment
Munno, O. D., & Sedie, A. D. (2011) · Reumatismo · doi:10.4081/reumatismo.2006.11 · Cited by 7
Botto, H., Neuzillet, Y., Lebrét, T., Camparo, P., Molinié, V., & Raynaud, J. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.023 · Cited by 8
A rational approach to androgen therapy for hypogonadal men with prostate cancer
Kaufman, J. M. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901401 · Cited by 8
Erythropoietin Resistance During Androgen Deficiency
Daniell, H. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1923-a · Cited by 8
Teikari, P., & Pietrusz, A. (2021) · SportRxiv (OSF Preprints) · doi:10.31236/osf.io/w734a · Cited by 14
Phytochemicals and Hormonal Effects
Oboh, G., Oyeleye, S. I., Ogunsuyi, O. B., & Adebayo, A. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.21743-5 · Cited by 8
The role of androgens in pressure overload myocardial hypertrophy
Schafstedde, M., & Nordmeyer, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1112892 · Cited by 7
Uso da testosterona no envelhecimento masculino
Calixto, I. T., & Prazeres, T. C. M. M. (2019) · Revista de Investigação Biomédica · doi:10.24863/rib.v10i3.315 · Cited by 7
DEFICIÊNCIA ANDROGÊNICA DO ENVELHECIMENTO MASCULINO E A REPOSIÇÃO DE TESTOSTERONA
Silva, K. R., & Linartevichi, V. F. (2021) · FAG JOURNAL OF HEALTH (FJH) · doi:10.35984/fjh.v3i1.306 · Cited by 7
The development of prostate cancer despite late onset androgen deficiency
Sengupta, S., DUNCAN, H. J., MacGregor, R. J., & Russell, J. M. (2005) · International Journal of Urology · doi:10.1111/j.1442-2042.2005.01172.x · Cited by 7
Use of Testosterone Replacement Therapy in Patients with Prostate Cancer
Dorff, T. B., & Vogelzang, N. J. (2011) · Current Urology Reports · doi:10.1007/s11934-011-0176-2 · Cited by 7
Bloomer, R. J., Gunnels, T. A., Moran, R. G., & Schriefer, J. M. (2015) · The Open Nutraceuticals Journal · doi:10.2174/1876396001508010043 · Cited by 7
Kim, M. K., Choi, S. Y., Kim, S. S., Kim, J. S., Boo, S. J., & Hur, J. (2016) · Journal of Ethnic Foods · doi:10.1016/j.jef.2016.08.005 · Cited by 7
Late onset hypogonadism in men
Kula, K., & Słowikowska‐Hilczer, J. (2012) · Endokrynologia Polska · Cited by 7
Ulrich, C., Trojanowicz, B., Fiedler, R., Kraus, F. B., Stangl, G. I., Girndt, M., & Seibert, E. (2021) · Nephron · doi:10.1159/000516636 · Cited by 7
Glucocorticoid-Induced Osteoporosis
Dubrovsky, A., Maricic, M. J., & Lane, N. E. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_21 · Cited by 6
Lari, M. A., Faramarz, H., Shams, M., MarzbanA, M., & Parsa, N. (2012) · Retrovirology · doi:10.1186/1742-4690-9-s1-p141 · Cited by 7
Testosterone replacement therapy
Jones, T. H. (2007) · British Journal of Hospital Medicine · doi:10.12968/hmed.2007.68.10.27326 · Cited by 7
Price, D. K., & Hsing, A. W. (2010) · Springer eBooks · doi:10.1007/978-1-60327-829-4_4 · Cited by 7
Healy, R., Patten, R. K., Bauer, C., Woessner, M. N., Bourke, M., Grossmann, M., & Levinger, I. (2024) · Sports Medicine - Open · doi:10.1186/s40798-024-00781-x · Cited by 7
Potter, N. J., Tomkinson, G. R., Dufner, T. J., Walch, T. J., Roemmich, J. N., Wilson, P. B., & Fitzgerald, J. S. (2021) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000004146 · Cited by 7
Ugo-Neff, G., & Rizzolo, D. (2022) · JAAPA · doi:10.1097/01.jaa.0000824956.78048.ff · Cited by 7
RETRACTED ARTICLE: The Effect of Testosterone on Men With Andropause
Sofimajidpour, H., Teimoori, T., & Gharibi, F. (2015) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.19406 · Cited by 6
RetractedEffects of dutasteride on serum free-testosterone and clinical significance of testosterone changes
Enatsu, N., Miyake, H., Haraguchi, T., Chiba, K., & Fujisawa, M. (2016) · Andrologia · doi:10.1111/and.12560 · Cited by 7
Glucocorticoid-Induced Osteoporosis
Adler, R. A., Weinstein, R. S., & Saag, K. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00049-2 · Cited by 6
Agretti, P., Pelosini, C., Bianchi, L., Grosso, A. D., Saba, A., Canale, D., & Sessa, M. R. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01304-7 · Cited by 6
Çimen, H. İ., Parnham, A. S., & Şerefoğlu, E. C. (2016) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2015.10.005 · Cited by 6
Aging in the Hypothalamic-Pituitary-Testicular Axis
Handelsman, D. J. (2006) · Elsevier eBooks · doi:10.1016/b978-012515400-0/50054-3 · Cited by 6
Testosteronsubstitution beim alternden Mann
Krause, W. K. H. (2004) · Der Urologe · doi:10.1007/s00120-004-0648-9 · Cited by 6
Tung, D. S., & Cunningham, G. R. (2007) · The Endocrinologist · doi:10.1097/01.ten.0000260860.68375.96 · Cited by 6
The good, the bad, and the unknown of late onset hypogonadism: the urological perspective
Jockenhövel, F., Kaufman, J. M., Mickisch, G., Morales, Á., & Wang, C. (2005) · The Journal of Men s Health and Gender · doi:10.1016/j.jmhg.2005.07.001 · Cited by 6
Halland, A., Jønler, M., & Pedersen, K. V. (2005) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590410002546 · Cited by 6
Testosterone and the Prostate: The Evidence So Far
Montorsi, F. (2007) · European Urology Supplements · doi:10.1016/j.eursup.2007.08.003 · Cited by 6
Hormonal Implications in the Development and Treatment of Prostate Cancer
Ip, C. C. K., & Hall, S. J. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.03.009 · Cited by 6
The role of accurate testosterone testing in the treatment and management of male hypogonadism
Dobs, A. S. (2008) · Steroids · doi:10.1016/j.steroids.2008.06.007 · Cited by 5
Żylicz, Z. (2009) · Via Medica Journals · Cited by 5
The testis, eunuchs, and testosterone: a historical review over the ages and around the world
Morgentaler, A., & Hanafy, H. M. (2023) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qead051 · Cited by 5
Moosig, F., Reinhold‐Keller, E., Holl‐Ulrich, K., Feller, A. C., Bley, T. A., Holle, J. U., Zwerina, J., Lamprecht, P., Dalhoff, K., Venhoff, N., et al. (2012) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-012-0988-6 · Cited by 5
Conners, W. P., & Morgentaler, A. (2013) · Current Urology Reports · doi:10.1007/s11934-013-0370-5 · Cited by 5
Testosterone Replacement Therapy: Who to Evaluate, What to Use, How to Follow, and Who is at Risk?
Afiadata, A., & ELLSWORTH, P. I. (2014) · Hospital Practice · doi:10.3810/hp.2014.12.1160 · Cited by 5
Dale, M. M., & Haylett, D. G. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-06773-0.00032-9 · Cited by 5
Glucocorticoid-Induced Osteoporosis
Maricic, M. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-459-9_25 · Cited by 5
Hypogonadism management and cardiovascular health
Auerbach, J. M., & Khera, M. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1805917 · Cited by 5
Androgen Replacement Therapy in Aging Men
Katz, A. (2004) · The Nurse Practitioner · doi:10.1097/00006205-200410000-00008 · Cited by 5
Testosterone replacement therapy
Cawley, M. A. (2009) · The Nurse Practitioner · doi:10.1097/01.npr.0000360150.79515.a8 · Cited by 5
Androgens, Male Hypogonadism and Traumatic Brain Injury
Hohl, A., Ronsoni, M. F., van de Sande‐Lee, S., Vieira, F. C. D. F., Schwarzbold, M. L., Díaz, A. P., & Walz, R. (2014) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2014.41002 · Cited by 5
New Concepts Regarding the Relationship of Testosterone and Prostate Cancer
Morgentaler, A. (2007) · Future Oncology · doi:10.2217/14796694.3.2.123 · Cited by 5
Diagnosis and treatment of hypogonadism in men seeking to preserve fertility – what are the options?
Lockie, A. W. C., Grice, P., Mathur, R., Pearce, I., & Modgil, V. (2024) · International Journal of Impotence Research · doi:10.1038/s41443-024-00897-4 · Cited by 4
Barnett, N., Ljubic, M., Chung, J. S., & Capizzi, A. N. (2024) · Neurorehabilitation · doi:10.3233/nre-230291 · Cited by 4
Min, K. S., & Kang, D. I. (2011) · Journal of Korean Medical Association · doi:10.5124/jkma.2011.54.2.197 · Cited by 4
Chu, K. Y., Kulandavelu, S., Masterson, T. A., Ibrahim, E., Arora, H., & Ramasamy, R. (2020) · F&S Science · doi:10.1016/j.xfss.2020.03.002 · Cited by 4
Antonič, K. G., Antonič, B., & Pfeifer, M. (2020) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2020.0008 · Cited by 4
Takeuchi, H., & Okubo, H. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10608 · Cited by 4
Sex Hormones and Immunosenescence
Gómez, C. R., Nomellini, V., & Kovacs, E. J. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_42 · Cited by 4
Morgentaler, A., McGettigan, J. W., Xiang, Q., Danoff, T. M., & Gould, E. M. (2014) · International Journal of Impotence Research · doi:10.1038/ijir.2014.28 · Cited by 4
Nerve growth factor as a new treatment for testosterone deficiency?
Morgentaler, A. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.017 · Cited by 4
Fortney, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00063-3 · Cited by 4
Yoshioka, M., Kosaki, K., Noma, S., Matsui, M., Kuro‐o, M., Shibata, A., Saito, C., Yamagata, K., Oka, K., & Maeda, S. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111717 · Cited by 4
Rising PSA during Testosterone Replacement Therapy.
Gore, J. L., & Rajfer, J. (2004) · Europe PMC (PubMed Central) · Cited by 4
Testosterone Replacement Therapy in Men with Prostate Cancer: What Is the Evidence?
Selph, J. P., & Carson, C. C. (2013) · Sexual Medicine Reviews · doi:10.1002/smrj.15 · Cited by 4
Gooren, L. J. (2006) · The Journal of Men s Health and Gender · doi:10.1016/j.jmhg.2006.10.002 · Cited by 4
Sexuality and intimacy after cancer
Potter, J. E., & Johnston, K. T. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1015-1.00057-6 · Cited by 4
Roantree, E., & Żylicz, Z. (2009) · Advances in Palliative Medicine · Cited by 4
Low Testosterone Level in Men and Quality of Life
Horie, S. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_152 · Cited by 4
Nutrition et insuffisance respiratoire
Pison, C. M., Fontaine, E. M., Barnoud, D., & Cano, N. (2007) · Springer eBooks · doi:10.1007/978-2-287-33475-7_63 · Cited by 4
Testosterone replacement therapy in hypogonadal men and prostate cancer risk
Kirby, R. S., & Gould, D. C. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05665.x · Cited by 4
Testosterone Substitution and the Prostate
Crawford, E. D. (2005) · European Urology Supplements · doi:10.1016/j.eursup.2005.05.004 · Cited by 4
Re: Prostate Cancer in Men Using Testosterone Supplementation
Morgentaler, A., Rhoden, E. L., Barqawi, A. B., & Crawford, E. D. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00691-9 · Cited by 4
Association Between Sarcopenia and the Long‐Term Risk of Intervertebral Disc Degeneration
Chen, J., Liang, T., Hu, W., Liao, N., Zhang, Z., Shi, H., Liu, S., Liang, J., Chen, Y., Lin, Y., et al. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70086 · Cited by 3
Klinaki, E., & Ogrodnik, M. B. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111929 · Cited by 3
NHG-Standaard Erectiele disfunctie
Leusink, P., Boer, J. L. D., Vlieland, W. C. V., Rambharose, R., Mogendorff, W. S., & Kortenhof, M. M. N. V. R.-V. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6614-9_83 · Cited by 3
Cavanagh, Y., Shah, N., Thomas, A., & Gupta, A. (2015) · Annals of Medical and Health Sciences Research · doi:10.4103/2141-9248.165259 · Cited by 3
Tan, J.-S., Chang, H.-C., Chung, S., Chen, P.-H., & Wu, W.-C. (2016) · Urological Science · doi:10.1016/j.urols.2016.03.001 · Cited by 3
Therapeutic Dilemmas for Androgen Deficiency in Aging Males
Salazar, J. A., & Tan, R. S. (2005) · Aging Health · doi:10.2217/1745509x.1.1.157 · Cited by 3
Estrategias para un envejecimiento exitoso
Ríos, A. M. O., Peña, T. L. V., & Prieto, L. M. G. (2015) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2015.10.001 · Cited by 3
Metadata
- Authors
- Rhoden, E. L., & Morgentaler, A.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- ORCID
- Morgentaler, Abraham
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-01-29
- Volume
- 350
- Issue
- 5
- Pages
- 482-492
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2120158027
- Cited by
- 705
- References
- 77
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 12 · 2023: 10 · 2022: 7 · 2021: 16 · 2020: 18 · 2019: 21 · 2018: 19 · 2017: 20 · 2016: 22 · 2015: 36 · 2014: 30 · 2013: 35 · 2012: 44
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- testosterone replacement therapy, risk, prostate cancer, older men, monitoring, androgen therapy, hypogonadism
- MeSH terms
- Cardiovascular Diseases, Humans, Hypogonadism, Lipids, Male, Polycythemia, Prostatic Diseases, Risk Factors, Testosterone, Drug Monitoring, Prostate-Specific Antigen, Age Distribution, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review